Abstract:Reduction-sensitive hyaluronic acid derivatives (HA–SS–COOH) were shielded on the DNA/polyethylenimine (PEI) to construct ternary complexes (DNA/PEI/HA–SS–COOH, DPS ternary complexes) with efficient gene transfection. Details studied were conducted to investigation of factors influencing transfection efficiency, including the gene compression by fluorescence resonance energy transfer (FRET) spectrum and the intracellular fate of fluorescent labeled complexes by the confocal laser scanning microscope (CLSM). In the FRET study, DPS complexes were found to enhance condensation of DNA in preparation, while timely loosen gene under exposure to reductive reagent. Similar cellular uptake levels were observed for the designed reduction sensitive complexes and the stable one (DNA/PEI/HA, DPH ternary complexes), but the intracellular process was strikingly different for the two types of complexes. Only DPS showed obvious desired intracellular deshielding and endosomal escape, which contributed to highly efficient gene delivery. After loading with p53 plasmid, DPS complexes achieved significantly up-regulated p53 tumor suppressor gene expression at both mRNA and protein levels, as revealed by quantitative polymerase chain reaction (qPCR) and western blot investigations. Transgene induced apoptosis was evaluated by propidium iodide staining and flow cytometry analysis of cell cycle. Tumor cells transfected by DPS complexes containing p53 gene displayed almost 50% higher suppression in proliferation compared to those untreated cells, accompanied with a 46% elevation in the number of cells at sub-G1 phase and remarkable p53 dependent cell cycle perturbations prior to apoptosis. These results demonstrated that targeted delivery of p53 gene via reduction-sensitive DPS ternary complexes enabled up-regulated cellular p53 mRNA level through the exogenous p53 gene, inducing a significant p53-dependent anti-proliferative effect on tumor cells, which could be effective means of cancer treatment.

Development of P53 Protein Transduction Therapy Using Membrane-Permeable Peptides and the Application to Oral Cancer Cells.

Targeting P53 by PTD-mediated Transduction

A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei.

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

Biotinylated Transferrin/avidin/biotinylated Disulfide Containing PEI Bioconjugates Mediated P53 Gene Delivery System for Tumor Targeted Transfection

Use of a Peptide Enhancing the Ability of Radiation Therapy to Kill Cancer Cells: a Patent Evaluation of WO2012016918.

Co-Delivery of Proapoptotic Peptide and P53 Dna by Reduction-Sensitive Polypeptides for Cancer Therapy

Inhibiting Bladder Tumor Growth with a Cell Penetrating R11 Peptide Derived from the P53 C-terminus.

Anti-tumor Efficacy of P53 with 9R Cell-Penetrating Peptides

Secretory expression of p53(N15)-Ant following lentivirus-mediated gene transfer induces cell death in human cancer cells.

Preliminary Study on the Feasibility of P53 Gene Delivery Mediated by Novel Vectors Constructed with CTS and PEI

Efficient P53 Activation and Apoptosis Induction of MDM2/MDMX Inhibitory Protein, a Recombinant Cell-Permeable Fusion Protein, in P53- Breast Cancer Cells.

Modulating Protein Protein Interactions in Vivo Via Peptide-Lanthanide-Derived Nanoparticles for Hazard-Free Cancer Therapy

Inhibition of Cell Proliferation and Migration Through Nucleobase-Modified Polyamidoamine-Mediated P53 Delivery

An archaeal histone-like protein mediates efficient p53 gene transfer and facilitates its anti-cancer effect in vitro and in vivo

A Cancer Cell Membrane Coated Nanoparticles-Based Gene Delivery System for Enhancing Cancer Therapy

Expression,purification and Transduction of PTD-p53 Fusion Protein to Hepatocellular Carcinoma Cell

p53 mediated apoptosis by reduction sensitive shielding ternary complexes based on disulfide linked PEI ternary complexes.

A Dual-Targeting Drug Co-Delivery System for Tumor Chemo- and Gene Combined Therapy.

Expression and Immunogenicity Analysis of p53 Protein Fused with a New Cell-Penetrating Peptide

Resurrecting a p53 peptide activator - An enabling nanoengineering strategy for peptide therapeutics